Abdullah Al Jefri

573 total citations
18 papers, 377 citations indexed

About

Abdullah Al Jefri is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Abdullah Al Jefri has authored 18 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 13 papers in Genetics and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Abdullah Al Jefri's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (11 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Abdullah Al Jefri is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (11 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Abdullah Al Jefri collaborates with scholars based in Saudi Arabia, Lebanon and Egypt. Abdullah Al Jefri's co-authors include Shahina Daar, Alì Taher, Amal El‐Beshlawy, Mohsen Saleh Elalfy, Dany Habr, Ulrike Kriemler‐Krahn, Abdel Hmissi, Timothy G. St. Pierre, Bernard Roubert and Diana Rofail and has published in prestigious journals such as Blood, Magnetic Resonance in Medicine and European Journal Of Haematology.

In The Last Decade

Abdullah Al Jefri

16 papers receiving 368 citations

Peers

Abdullah Al Jefri

HEMAT

GENET

PPCH

EPIDE

Lee Lee Chan Malaysia

Güngör Nişli Türkiye

Bunchoo Pongtanakul Thailand

Elena Cela Spain

G Pizzarelli Italy

Cristina Beléndez Spain

İlgen Şaşmaz Türkiye

Ian Thornley Canada

Sue Height United Kingdom

Antonios Bilalis Greece

Lee Lee Chan Malaysia

Abdullah Al Jefri

256 ×0.9

HEMAT

243 ×0.8

GENET

79 ×1.0

PPCH

18 ×0.3

EPIDE

40 ×1.3

Citations per year, relative to Abdullah Al Jefri Abdullah Al Jefri (= 1×) peers Lee Lee Chan

Countries citing papers authored by Abdullah Al Jefri

Since Specialization

Citations

This map shows the geographic impact of Abdullah Al Jefri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Al Jefri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Al Jefri more than expected).

Fields of papers citing papers by Abdullah Al Jefri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Al Jefri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Al Jefri. The network helps show where Abdullah Al Jefri may publish in the future.

Co-authorship network of co-authors of Abdullah Al Jefri

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Al Jefri. A scholar is included among the top collaborators of Abdullah Al Jefri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Al Jefri. Abdullah Al Jefri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Pierre, Timothy G. St., Amal El‐Beshlawy, Mohsen Saleh Elalfy, et al.. (2013). Multicenter validation of spin‐density projection‐assisted R2‐MRI for the noninvasive measurement of liver iron concentration. Magnetic Resonance in Medicine. 71(6). 2215–2223. 96 indexed citations

Shinwari, Jameela, Tahani Alshehri, Asma I. Tahir, et al.. (2013). Variable <i>β</i>-globin haplotypes in Saudi <i>β</i> thalassemia population. 3(3). 171–173. 1 indexed citations

Hajjar, Sami Al, Saleh Al Muhsen, Mouhab Ayas, et al.. (2011). Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients. Hematology/Oncology and Stem Cell Therapy. 4(2). 67–72. 10 indexed citations

Taher, Alì, Mohsen Saleh Elalfy, Shahina Daar, et al.. (2011). Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β‐thalassaemia: results from the ESCALATOR study. European Journal Of Haematology. 87(4). 349–354. 9 indexed citations

Taher, Alì, Mohsen Saleh Elalfy, Shahina Daar, et al.. (2011). Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7‐yr follow‐up from the ESCALATOR study in patients with β‐thalassaemia. European Journal Of Haematology. 87(4). 355–365. 28 indexed citations

Owaidah, Tarek, et al.. (2011). Noval Mutation in Four Saudi Families with Glanzmann Thrombasthenia. Blood. 118(21). 1136–1136.

Taher, Alì, Abdullah Al Jefri, Mohsen Saleh Elalfy, et al.. (2010). Improved Treatment Satisfaction and Convenience with Deferasirox in Iron-Overloaded Patients with β-Thalassemia: Results from the ESCALATOR Trial. Acta Haematologica. 123(4). 220–225. 36 indexed citations

Boztuǧ, Kaan, Xiaoqi Ding, Hans Hartmann, et al.. (2010). HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI. American Journal of Medical Genetics Part A. 152A(12). 3157–3163. 20 indexed citations

Pierre, Timothy G. St., Amal El‐Beshlawy, Mohsen Saleh Elalfy, et al.. (2010). Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Non-Invasive Measurement of Liver Iron Concentration. Blood. 116(21). 2053–2053. 5 indexed citations

10.

Taher, Alì, Amal El‐Beshlawy, Mohsen Saleh Elalfy, et al.. (2009). Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron‐overloaded patients with β‐thalassaemia: the ESCALATOR study. European Journal Of Haematology. 82(6). 458–465. 126 indexed citations

11.

Taher, Alì, Amal El‐Beshlawy, Mohsen Saleh Elalfy, et al.. (2008). Efficacy and Safety of Once-Daily Oral Deferasirox (Exjade®) during a Median of 2.7 Years of Treatment in Heavily Iron-Overloaded Patients with β-Thalassemia. Blood. 112(11). 5409–5409. 3 indexed citations

12.

Taher, Alì, Abdullah Al Jefri, Mohsen Saleh Elalfy, et al.. (2008). Deferasirox (Exjade®) Treatment in Pediatric β-Thalassemia Patients with High Iron Burden: 2.8 Years Results from ESCALATOR Trial. Blood. 112(11). 3879–3879. 1 indexed citations

13.

Taher, Alì, Abdullah Al Jefri, Mohsen Saleh Elalfy, et al.. (2007). Oral Deferasirox (Exjade®, ICL670) Is Effective, with a Clinically Manageable Safety Profile, in Pediatric β-Thalassemia Patients with High Iron Burden.. Blood. 110(11). 2779–2779. 2 indexed citations

14.

Taher, Alì, Amal El‐Beshlawy, Abdullah Al Jefri, et al.. (2006). Deferasirox (Exjade®, ICL670) Is Effective and Tolerable in β-Thalassemia Patients with High Iron Burden and History of Inadequate Chelation Therapy.. Blood. 108(11). 3823–3823. 1 indexed citations

15.

Jefri, Abdullah Al, et al.. (2006). ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) FOR PATIENTS (PTS) WITH THALASSEMIA MAJOR: THE ASIAN EXPERIENCES. 31–32.

16.

Taher, Alì, Amal El‐Beshlawy, Abdullah Al Jefri, et al.. (2005). Deferasirox (Exjade®, ICL670) Treatment of Inadequately Chelated β-Thalassemia Patients from the Middle East: The ESCALATOR Trial.. Blood. 106(11). 3840–3840. 2 indexed citations

17.

Seth, Pankaj, M. Aslam, Hassan El Solh, et al.. (2004). Second Allogeneic Bone Marrow Transplantation after Myeloablative Conditioning Analysis of 43 Cases from Single Institution. Hematology. 9(2). 123–129. 17 indexed citations

18.

Jenkin, R. D. T., Mohamed Alshabanah, Rhomes J. A. Aur, et al.. (2000). Extramedullary Myeloid Tumors in Children: The Limited Value of Local Treatment. The American journal of pediatric hematology/oncology. 22(1). 34–40. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact